Clinical Trials in Chicago

Showing 8521-8540 of 20,493 trials

Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite

NCT04677712

This study will investigate treatments that may mitigate bruising after QWO™ (Collagenase clostridium histolyticum \[CCH\]-aaes) treatment of cellulite in the buttocks.

Edematous Fibrosclerotic Panniculopathy (EFP)Cellulite

Endo Pharmaceuticals48 participantsStarted Dec 2020

Scottsdale, Arizona, United States • Sacramento, California, United States • San Diego, California, United States +5 more locations

COMPLETED2.2 miles

A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

NCT01770951

The objective of this retrospective trial is to assess safety and efficacy of eculizumab in aHUS patients treated outside of an Alexion-sponsored controlled clinical trial.

Atypical Hemolytic Uremic Syndrome (aHUS)

Alexion Pharmaceuticals, Inc.30 participantsStarted Aug 2009

Dunwoody, Georgia, United States • Chicago, Illinois, United States • Portland, Maine, United States +20 more locations

Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite

A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

Find Trials by Condition in Chicago

Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.

Real World Perspectives on Advancements in Hearing Aid Technology

A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM)

Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL

BioVentrix Revivent TC™ System Clinical Study

M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)

A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer

Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study

Pilot Clinical Performance of a Silicone Hydrogel Lens for Up to Six Nights of Extended Wear

A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy

Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.

Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

BMS-986325 in Healthy Participants and Participants With Primary Sjögren's Syndrome